AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Elopak ASA

Quarterly Report Oct 28, 2025

3592_rns_2025-10-28_f9b517bb-ef21-4ce6-90a4-431b21ba3ddf.pdf

Quarterly Report

Open in Viewer

Opens in native device viewer

Third quarter 2025 highlights

  • Highest EBITDA to date of EUR 49.1 million and a strong 17.0% margin with organic revenue growth of 1.2%
  • Strong sales growth in the Americas, up 18% year-over-year on a constant currency basis. The new U.S. plant in Little Rock continues to ramp up commercial production, successfully delivering its first profitable quarter
  • Decision to accelerate capacity expansion in Little Rock with 30 MUSD investment in a third production line
  • The Group's balance sheet improved during the quarter, with solid cash flow reducing net debt by EUR 34 million and leverage to 2.1x

Key figures

Q3 Q3 YTD YTD LTM FY
(EUR million) 2025 2024 2025 2024 2025 2024
Revenue 289.7 292.8 889.6 873.1 1 173.1 1 156.6
Revenue growth -1.1% 3.3% 1.9% 3.3% 1.1% 2.2%
EBITDA 1) 49.1 45.4 138.5 135.3 179.3 176.1
EBITDA margin 1) 17.0% 15.5% 15.6% 15.5% 15.3% 15.2%
EBITDA growth 8.3% 2.4% 2.3% 3.0%
Adjusted profit attributable to Elopak shareholders 18.1 15.2 44.3 52.7 56.4 64.8
Adjusted basic and diluted earnings per share (in EUR) 2) 0.07 0.06 0.16 0.20 0.21 0.24
Leverage ratio 1) 2.1 2.1 2.1
ROCE 1) 14.8% 16.8% 15.9%
TRI rate 3) 4.2 5.4 4.3

1) Definition of Alternative Performance Measures (APM), including specification for adjustments, at the end of this report

2) Adjusted basic and diluted EPS LTM is calculated based on quarterly EPS values

3) Total Recordable Injury (TRI) frequency rate, last twelve-month average

CEO comments:

Delivering profitability and progress – a strong quarter powered by Americas

The third quarter of 2025 was a new milestone quarter for Elopak, delivering the highest EBITDA results to date of EUR 49.1 million. This reflects the continued execution of our long-term strategy, with visible progress in scaling our global footprint and advancing the transition to more sustainable packaging. In addition, our U.S. plant in Little Rock delivered its first profitable quarter, an important milestone as we continue to ramp up production throughout the rest of 2025.

There is solid demand for our products and services across the US. To ensure we can meet this we have decided to accelerate the expansion of the capacity in Little Rock by investing in a third production line about one year ahead of the original plan. The expansion is backed by long-term customer commitments for a material part of the production capacity and will enable a broader product portfolio to better serve and grow with our customers, including the production of a mix of smaller Pure-Pak® formats for the school milk and fresh dairy segments. The investment is a reaffirmation of our strategic priority to realize global growth and become the leading partner for high-quality, fiber-based packaging solutions in the Americas. With the three announced production lines, we will be able to reach our mid- and longterm revenue target for Americas of EUR 480 million and EUR 550 million, respectively, as presented at our Capital markets day in September 2024.

Our strategy introduced in September 2024, "Repackaging Tomorrow", is built around three priorities: realizing global growth, strengthening leadership in our core markets, and leveraging the plastic replacement shift, all underpinned by our position as sustainability frontrunner.

During Climate Week in New York, I had the opportunity to share our knowledge of how fiberbased cartons can help reduce plastic dependency in food systems, cut emissions, and support circularity. It's clear that sustainability is no longer a niche concern-it's a strategic imperative for our customers, our industry, and our planet.

In Europe, we are navigating a complex market environment shaped by changing consumption behavior, regulatory developments, and competitive dynamics. In the southern parts of Europe

and MENA we increasingly see consumers shifting from fresh to longer shelf-life products, including aseptic both within the dairy and juice segments. Our strong market position and leading innovation capabilities both within packaging solutions and filling machines allow us to respond to these changing behaviors and to continue to grow our market position. This is supported by strong momentum for our state-of-the-art filling machine offerings with several signings in the quarter and ongoing discussions for more, both within fresh and aseptic.

In India, we continue our work to unlock growth in the world's largest dairy market through the introduction of our fresh Pure-Pak® cartons, receiving positive interest from multiple customers in India. In the short term, growth in Roll Fed will continue to be volatile as high competition and new supply settle into the market.

As part of our strategy to lead the way in the global plastic-to-carton megatrend, we continue to develop our D-PAK™ carton solutions. While the conversion is happening somewhat slower than expected, there is a growing interest in our sustainable fiber solutions, with several partners now onboard. This shift will not only support our sustainability ambitions but open significant growth opportunities across adjacent markets.

As we embark on the last quarter of 2025, we remain focused on executing our strategy and delivering on our mid-term targets. The expansion in Little Rock and our investments in innovation and sustainability position Elopak to lead the industry transition toward low-carbon, fiber-based packaging solutions.

For the full year, we expect the solid performance to continue, leading us to deliver organic revenue growth within our mid-term target range of 4-6% and full-year EBITDA margin above 15%, in line with our financial guidance throughout the year.

"This quarter demonstrates how our strategy is translating into real progress - realizing growth in our global markets, expanding our product portfolio to better serve and grow with our customers, and advancing the shift away from plastics. The profitability milestone in Little Rock and the decision to invest in a third production line reflects our confidence in the Americas and our commitment to long-term partnerships and to sustainable, high-quality packaging solutions, that meet our customer's needs"

Thomas Körmendi, Chief Executive Officer

Financial review

Group

Reported revenue for the Group in the third quarter declined by 1.1% compared to the same period last year, primarily due to unfavorable currency movements. However, on a constant currency basis, organic revenue increased by 1.2% year-over-year. We saw strong revenue growth in Americas, mainly driven by the ramp-up of the new U.S. plant. This was partially offset by lower sales of filling machines, reflecting changes in the machine mix and timing of commissioning between periods.

EBITDA for the quarter amounted to EUR 49.1 million, an increase of EUR 3.8 million year-onyear, corresponding to an EBITDA margin of 17.0%, up from 15.5% in Q3 2024. The margin improvement was mainly driven by growth in Americas, as well as a favorable product mix in EMEA.

Year-to-date, Group revenues totaled EUR 889.6 million, reflecting reported growth of 1.9% and organic growth of 2.9%. EBITDA reached EUR 138.5 million, an improvement of EUR 3.2 million compared to the same period last year. This corresponds to an EBITDA margin of 15.6%, up from 15.5% in the prior year.

Group financials (EUR million)

EMEA

In the third quarter of 2025, revenues in EMEA amounted to EUR 206.2 million (EUR 217.7 million), equal to an organic decline of 4.8%.The decline was primarily driven by timing and mix differences of filling machine commissioning. Additionally, the Roll Fed segment in Europe continued to face sustained competition, resulting in lower volumes compared to Q3 2024, although the decrease was smaller than in earlier periods.

Pure-Pak® and closure revenues in EMEA remained stable year-on-year. Pricing in Europe, volume growth in MENA, and increased market share in Southern Europe helped offset reduced consumption in the European dairy and juice markets. The MENA region delivered positive year-over-year volume growth, with this year's stable performance contrasting with last year's results, which were negatively impacted by macroeconomic volatility.

In India, our Roll Fed business continued to grow, recording an 19% increase in organic revenue year-on-year. While volumes developed positively compared to the previous year, they were affected by stronger price competition and a mild summer season, which led to a softer demand for juice. As Roll Fed products generally carry lower margins than Pure-Pak® cartons, India had a dilutive effect on the Group EBITDA margin, which was further intensified during the quarter.

EBITDA for the quarter was EUR 36.7 million (EUR 35.9 million), resulting in an EBITDA margin of 17.8% (16.5%). The improved margin was primarily driven by a positive one-off effect of EUR 1.5 million and a favorable product mix. These gains were partially offset by inflationary pressure on the fixed cost base and increased investments in R&D, in line with our strategic plan. Year-on-year improvements in waste reduction and operational efficiency also contributed positively to overall financial performance.

Year-to-date revenues in EMEA amounted to EUR 655.8 million, representing a 1.8% decline. EBITDA was EUR 107.5 million (EUR 108.8 million), with a margin of 16.4% (16.3%).

EMEA financials (EUR million)

Americas

In Americas, revenues reached EUR 88.2 million, representing an increase of 11.2% compared to the same quarter last year, or 18.4% growth when adjusted for currency effects. The strong growth was driven by increased sales of cartons and closures (EUR 15.3 million), partly offset by lower revenue from filling machines due to machine mix (EUR -5.5 million).

Carton and closure revenues were primarily supported by the ramp-up of our new plant in the U.S., combined with strong volumes from the legacy plant. The onboarding of new customers in Little Rock has improved compared to the previous quarter, but it is still taking more time than originally anticipated. Growth was fueled by increased demand from both existing and new customers across all segments. We continue to experience strong demand as dairies focus on securing their supply through dual sourcing, where Elopak is perceived as a provider of modern solutions and high-quality products. Carton pricing, aligned with raw material cost increases, also contributed to the revenue uplift.

Although the volume of filling machines sold remained stable year-over-year, the machines sold during the current period were primarily designated for the school milk segment. This segment typically involves lower-cost machinery than other market segments, resulting in a EUR 5.5 million decrease in equipment revenue.

EBITDA amounted to EUR 21.3 million (EUR 17.6 million), resulting in a margin of 24.1% (22.2%). The margin improvement during the quarter was mainly driven by a favorable product mix, enhanced operational efficiency, and waste reductions, which collectively contributed to increased production output. Additionally, the U.S. plant delivered its first profitable EBITDA in the quarter, marking a significant milestone. The share of net income from joint ventures was EUR 1.4 million, compared to EUR 2.1 million in the same quarter last year. The decline was primarily due to softer demand and change in consumption habits.

On a year-to-date basis, revenues in the Americas totaled EUR 260.0 million, reflecting reported growth of 14.9% and organic growth of 18.4%. EBITDA was EUR 57.5 million (EUR 52.1 million), with a margin of 22.1% (23.0%).

Americas financials (EUR million)

Profit

In the third quarter of 2025, operating profit was EUR 29.8 million, an improvement of EUR 3.2 million compared to the same period last year. Depreciation and amortization increased EUR 1.2 million, to EUR 17.8 million primarily due to depreciation of the US plant. The remaining development is described in the EBITDA section of the report.

Net financial items for the quarter amounted to EUR -4.0 million, compared to EUR -11.5 million in the same quarter last year. This reduction in the net financial expense was primarily driven by positive fair value changes on the interest rate swap of EUR 4.6 million as future EUR interest rate expectations has increased compared to the same quarter in 2024 and EUR 0.3 million gain on foreign exchange compared to a loss of EUR 1.6 million in the same period last year, excluding the foreign exchange effects on the NOK bonds.

The tax expense for the quarter was EUR 9.0 million (EUR 1.6 million), representing 33% of profit before tax. This includes a 25% weighted average tax rate, before joint ventures and ad justed for known permanent differences, includ ing withholding tax on dividends from Canada this quarter. See Note 5 for more details.

Profit attributable to Elopak shareholders was EUR 18.1 million (EUR 15.2 million) in the quarter.

Year-to-date operating profit was EUR 82.7 million, an improvement of EUR 2.5 million. Profit before tax from continuing operations was EUR 62.1 million, down EUR 6.5 million. Profit attributable to Elopak shareholders decreased by EUR 8.2 million, to EUR 44.3 million.

Cash flow and financial position

In the third quarter, the Group strengthened its financial position through strong cash flow generation from operations, moderate investment levels, and cash flow related to financing activities. Net financial debt was reduced by EUR 30.4 million, and the leverage ratio improved to 2.1x, down from 2.3x in the second quarter.

Cash flow from operations amounted to EUR 54.9 million, reflecting an EBITDA of EUR 49.1 million, positive cash effects from working capital of EUR 15.8 million, and taxes paid of EUR 7.7 million, adjusted for net income from joint ventures of EUR 1.4 million. The improvement in work ing capital was primarily driven by the timing of trade payables (EUR 13.9 million), optimization of packaging material inventories in Europe (EUR 4.7

million), and sum of other favorable effects (EUR 3.8 million), somewhat offset by the ramp-up of our new plant in the U.S. (EUR 5.9 million). Trade receivables increased in line with sales during the period, with an impact of EUR 1.8 million, while cash from our filling machine operations improved by EUR 1.4 million due to the signing of new customer contracts.

Net cash flow from investing activities totaled EUR -11.5 million, reflecting continued investments in the new U.S. plant (EUR 2.4 million), as well as new equipment and maintenance programs in EMEA. Filling machine projects in Europe were below last year's level, despite a stable number of commissionings, as the majority were financed as sales.

Cash flow related to financing activities amounted to EUR -11.5 million, including lease payments of EUR 5.9 million, interest payments of EUR 4.5 million on existing debt, and the purchase of treasury shares totaling EUR 1.0 million.

Year-to-date, cash flow from operations amounted to EUR 108.4 million, cash flow to investments totaled EUR -58.0 million, and cash flow to financing activities reached EUR -30.1 million.

1) Cash flow from financing excluding changes in financial debt

2) Net payments on supply chain financing reclassified from financing to operations in Q2 2025

3) FX relates to translation of NOK bonds. The bonds are fully hedged, however the hedge instruments are not part of net debt

ROCE increased by 0.2 percentage points in the third quarter, reaching 14.8% at the end of September. This improvement was primarily driven by higher EBIT over the last twelve months, which rose by EUR 2.5 million to EUR 109.6 million. Capital employed increased by EUR 5.8 million compared to June 30, 2025, mainly due to continued investment activity in the new U.S. plant and equipment and maintenance programs in EMEA.

Consolidated statement of income

Quarter ended September 30, Year to date ended September 30, Full year*
(EUR 1 000)
NOTE
2025 2024 2025 2024 2024
Revenues
2
289 648 292 804 889 588 873 110 1 156 502
Other operating income 31 24 34 25 89
Total income
3
289 679 292 827 889 622 873 136 1 156 591
Cost of materials (173 582) (184 835) (547 991) (544 932) (719 753)
Payroll expenses (51 570) (49 820) (157 257) (151 093) (203 243)
Depreciation and amortization expenses (17 759) (16 567) (49 587) (47 369) (64 377)
Impairment of non-current assets (176) (97) (1 246) (672) (2 568)
Other operating expenses (16 814) (14 922) (50 843) (48 823) (67 195)
Total operating expenses (259 900) (266 242) (806 924) (792 889) (1 057 136)
Operating profit
3
29 779 26 586 82 698 80 247 99 456
Financial income 5 760 5 614 17 597 11 644 18 291
Financial expenses (10 637) (11 498) (32 506) (26 213) (38 581)
Foreign exchange gain/(loss) (2 310) 4 229 (13 944) 1 836 6 809
Fair value changes on financial instruments 3 163 (9 863) 3 302 (5 959) (6 918)
Net financial items (4 024) (11 517) (25 550) (18 691) (20 399)
Share of net income from joint ventures 1 431 2 127 4 942 6 981 9 696
Profit before tax from continuing operations 27 185 17 196 62 090 68 537 88 753
Income tax
4
(9 000) (1 639) (17 235) (14 493) (27 203)
Profit from continuing operations 18 185 15 556 44 856 54 043 61 550
Discontinued operations Russia
Profit/(loss) from discontinued operations
-
-
-
-
-
-
(131)
(131)
603
603
Profit/(loss) 18 185 15 556 44 856 53 912 62 153
Profit attributable to:
Elopak shareholders 18 138 15 169 44 336 52 540 60 912
Non-controlling interest 47 387 520 1 372 1 241
Basic and diluted earnings per share from continuing operations (in EUR) 0.07 0.06 0.16 0.20 0.22
Basic and diluted earnings per share from discontinued operations (in EUR) 0.00 0.00 0.00 0.00 0.00
Basic and diluted earnings per share attributable to Elopak shareholders (in EUR) 0.07 0.06 0.16 0.20 0.23

Q3 report 2025 11 *Audited

Consolidated statement of comprehensive income

Quarter ended September 30, Year to date ended September 30, Full year*
(EUR 1 000) 2025 2024 2025 2024 2024
Items that will not be reclassified subsequently to profit or loss
Actuarial gain/(loss) on defined benefit pension plans, net of tax (7) 27 (5) 38 171
Items reclassified subsequently to net income upon
derecognition
Exchange differences on translation foreign operations Elopak shareholders (905) (11 241) (23 183) (7 543) 7 636
Exchange differences on translation foreign operations
non-controlling interest
(348) (477) (1 577) (189) 317
Net value gain/(loss) on cash flow hedges, net of tax 1 273 1 466 2 721 2 420 973
Other comprehensive income, net of tax 14 (10 226) (22 043) (5 274) 9 096
Total comprehensive income 18 199 5 331 22 813 48 638 71 249
Total comprehensive income attributable to:
Elopak shareholders 18 500 5 421 23 870 47 456 69 691
Non-controlling interest (301) (90) (1 057) 1 182 1 557

*Audited

*Audited 12

Consolidated statement of financial position

(EUR 1 000) September 30, September 30, December 31,
ASSETS NOTE 2025 2024 2024*
Development cost and other intangible assets 45 649 54 201 52 915
Deferred tax assets 20 864 19 883 22 295
Goodwill 106 753 105 947 107 584
Property, plant and equipment 270 568 228 298 265 013
Right-of-use assets 85 669 91 841 91 979
Investment in joint ventures 41 193 39 401 37 793
Other non-current assets 14 573 14 105 13 111
Total non-current assets 585 269 553 677 590 691
Inventory 193 416 191 077 197 934
Trade receivables 111 727 114 760 120 226
Other current assets 125 531 128 872 118 508
Cash and cash equivalents 39 077 21 325 28 052
Total current assets 469 750 456 034 464 720
Total assets 1 055 020 1 009 711 1 055 411

*Audited

(EUR 1 000) September 30, September 30, December 31,
EQUITY AND LIABILITIES NOTE 2025 2024 2024*
Attributable to Elopak shareholders 342 609 319 432 342 052
Non-controlling interest 9 543 10 225 10 600
Total equity 352 152 329 657 352 652
Pension liabilities 2 093 2 314 2 221
Deferred tax liabilities 13 378 13 495 14 578
Non-current interest bearing liabilities 280 544 232 708 259 740
Non-current lease liabilities 78 324 83 088 83 219
Other non-current liabilities 7 838 8 971 9 216
Total non-current liabilities 382 178 340 576 368 975
Current interest bearing liabilities 29 927 52 908 30 383
Current non-interest bearing liabilities1) 41 465 45 427 39 782
Trade payables 1 70 122 70 951 73 304
Taxes payable 13 263 921 5 294
Public duties payable 24 069 23 441 25 952
Current lease liabilities 21 599 22 973 23 312
Other current liabilities 120 246 122 858 135 756
Total current liabilities 320 690 339 478 333 784
Total liabilities 702 868 680 054 702 759
Total equity and liabilities 1 055 020 1 009 711 1 055 411

*Audited

1) Supply chain financing presented as current non-interest bearing liabilities from December 2024. The comparative numbers have been restated.

Consolidated statement of cash flows

Quarter ended
September 30,
Year to date ended
September 30,
Full year
(EUR 1 000) 2025 2024 2025 2024 2024*
Profit before tax from:
Continuing operations 27 185 17 196 62 090 68 537 88 753
Discontinued operations - - - (131) 603
Profit before tax (including discontinued operations) 27 185 17 196 62 090 68 405 89 356
Interest on borrowings 4 520 4 214 13 588 10 996 15 304
Lease liability interest 1 897 2 003 5 795 5 888 7 892
Profit before tax and interest paid 33 602 23 412 81 474 85 290 112 552
Depreciation, amortization and impairment losses 17 935 16 664 50 833 48 040 66 945
Net (gains), losses from disposals, impairments and change (3 673) 6 981 (2 936) 3 602 1 719
in fair value of financial assets and liabilities
Net unrealized currency (gain)/loss 382 (2 842) 8 929 (2 344) (4 558)
Income from joint ventures (1 431) (2 127) (4 942) (6 981) (9 696)
Net (gain)/loss on sale of non-current assets (5) (0) 8 10 56
Income taxes paid (7 743) (5 243) (16 677) (22 114) (27 299)
Change in trade receivables (1 780) (10 451) 2 196 (5 447) (6 991)
Change in other current assets (5 141) (9 094) (119) (3 207) 79
Change in inventories 476 5 366 588 922 (752)
Change in trade payables 13 945 (16 057) (919) (15 070) (15 755)
Net payments on supply chain financing 1) 262 684 1 683 4 961 (684)
Change in other current liabilities 8 106 4 344 (11 618) 6 560 23 800
Change in net pension liabilities (23) (74) (115) (147) (148)
Net cash flow from operating activities 54 912 11 562 108 384 94 076 139 265
Purchase of non-current assets (11 826) (28 872) (57 625) (68 099) (109 101)
Proceeds from sale of financial assets and businesses 253 2 028 1 422 2 028 2 028
Dividend from joint ventures 0 - 0 4 018 9 866
Change in other non-current assets 40 (1 660) (1 796) (849) (306)
Net cash flow from investing activities (11 533) (28 504) (58 000) (62 902) (97 513)
Quarter ended
September 30,
Year to date ended
September 30,
Full year
(EUR 1 000) 2025 2024 2025 2024 2024*
Proceeds from and repayments of borrowings (25 574) 32 154 27 211 40 949 45 599
Interest on borrowings (4 520) (4 214) (13 588) (10 996) (15 304)
Lease payments (5 917) (5 952) (19 067) (16 991) (23 589)
Dividend paid to equity holders of Elopak ASA 0 - (21 637) (34 430) (34 430)
Purchase of treasury shares (1 021) (1 589) (3 063) (1 589) (1 814)
Net cash flow from financing activities (37 033) 20 400 (30 144) (23 058) (29 538)
Effects of exchange rate changes on cash and cash equiv (1 400) ( 185) (9 216) (100) 2 529
alents
Net change in cash and cash equivalents 4 946 3 274 11 025 8 017 14 744
Cash and cash equivalents at the beginning of the period 34 131 18 052 28 052 13 308 13 308
Cash and cash equivalents at the end of the period 39 077 21 325 39 077 21 325 28 052

*Audited

1) Supply chain financing presented as current non-interest bearing liabilities from December 2024 are presented as operating activites. The comparative numbers have been restated.

Consolidated statement of changes in equity

September 30, 2025

(EUR 1 000) Note Share
capital
Other paid
in capital
Currency trans
lation reserve
Cash flow
hedge reserve
Retained
earnings
Non-controlling
interest
Total
equity
Total equity 01.01 50 112 71 701 (19 467) (3 302) 243 007 10 600 352 651
Profit for the period - - - - 44 336 520 44 856
Other comprehensive income for the period net of tax - - (23 183) 2 721 (5) (1 577) (22 043)
Total comprehensive income for the period - - (23 183) 2 721 44 331 (1 057) 22 813
Dividend paid - - - - (21 637) - (21 637)
Share based payments - 279 - - (1 145) - (866)
Treasury shares (41) (769) - - - - (810)
Total capital transactions in the period (41) (490) - - (22 782) - (23 313)
Total equity 30.09 6 50 071 71 211 (42 649) (580) 264 555 9 543 352 151

September 30, 2024

(EUR 1 000) Note
capital
Share
Other paid
in capital
Currency trans
lation reserve
Cash flow
hedge reserve
Retained
earnings
Non-controlling
interest
Total
equity
Total equity 01.01 50 104 70 548 (27 103) (4 275) 216 977 9 043 315 295
Profit for the period -
-
- - 52 540 1 372 53 912
Other comprehensive income for the period net of tax -
-
(7 543) 2 420 38 ( 189) (5 274)
Total comprehensive income for the period -
-
(7 543) 2 420 52 579 1 182 48 638
Dividend paid -
-
- - (34 430) - (34 430)
Share based payments -
1 443
- - ( 224) - 1 219
Treasury shares ( 38)
(1 026)
- - - - (1 064)
Total capital transactions in the period ( 38)
417
- - (34 654) - (34 275)
Total equity 30.09 50 066 70 964 (34 646) (1 854) 234 902 10 225 329 657

Notes to the condensed interim financial statements

Note 1 Company information and basis of preparation

The Elopak Group consists of Elopak ASA and its subsidiaries. Elopak ASA is a public limited company incorporated in Norway and listed on Oslo Stock Exchange. The Elopak Group is a leading global supplier of carton packaging and filling equipment, which supplies both the fresh and aseptic segments. The consolidated financial information has not been subject to audit or review.

All numbers are presented in EUR 1 000 unless otherwise is clearly stated. The subtotals in some of the tables may not equal the sum of the amounts shown due to rounding. Certain amounts in the comparable periods in the note disclosures have been reclassified to conform to current period presentation.

The Board of Directors approved the condensed consolidated interim financial statements for the period ended September 30, 2025 on October 27, 2025.

Basis of preparation

The condensed consolidated interim financial statements have been prepared in accordance with International Financial Reporting Standard (IFRS), IAS 34 "Interim Financial Reporting". The condensed interim financial statements do not include all information and disclosures required in the annual financial statement and should be read in conjunction with the Group's Annual Report for 2024, which has been prepared according to IFRS as adopted by EU. The accounting policies applied in the preparation of the consolidated interim financial statements are consistent with those applied in the preparation of the annual IFRS financial statements for the year ended December 31, 2024.

The preparation of interim financial statements requires the Group to make certain estimates and assumptions that affect the application of accounting policies and reported amounts of assets, liabilities, income, and expenses. Estimates and judgements are continually evaluated by the company based on historical experience and other factors, including expectations of future events that are deemed to be reasonable under the circumstances. Actual results may differ from these estimates. The most significant judgements used in preparing these interim financial statements and the key areas of estimation uncertainty are the same as those applied in the consolidated annual report for 2024.

The annual report for 2024 provides a description of the uncertainties and risks for the business.

The Group had introduced supply chain financing for some vendors and in some circumstances the payment terms in the contract with the vendor are linked to the supply chain financing arrangement. In such circumstances, the payable for the services or goods delivered are reclassified from trade payables to current non-interest-bearing liabilities, and the cash outflow to the financial institution has been presented as operating activities in the statement of cash flows previously categorized as financing activities in Q4 2024 and Q1 2025.

Note 2 Revenues

The Group's revenues consist of revenue from contracts with customers (99%) and rental income from lease of filling equipment (1%). Revenues are primarily derived from the sale of cartons and closures, sales and rental income related to filling equipment and service. The tables include continuing operations only.

As described in the accounting policy for revenues in the annual report for 2024, and in compliance with IFRS 15, the Group recognizes revenue over time for goods without alternative use where the Group has a legally enforceable right to payment. This gives a positive effect on revenue and EBITDA in times where the inventory level of such goods is increasing and negative effect in times where the inventory level of such goods is decreasing. The impact on EBITDA for the quarter is EUR 0.8 million for 2025 and EUR 0.1 million for 2024.

Revenues specified by geographical area Quarter ended September 30 Year to date ended September 30
(EUR 1 000) 2025 2024 2025 2024
USA 71 889 60 647 209 875 172 054
Germany 35 386 44 068 114 640 124 114
Canada 18 401 20 554 57 951 59 994
Netherlands 18 624 15 402 54 838 46 722
Norway 5 725 4 784 15 763 15 579
Other 139 624 147 349 436 521 454 647
Total revenue 289 648 292 804 889 588 873 110

The revenues are specified by location (country) of the customer.

Revenues by product and operating segment

(EUR 1 000) Other and
Quarter ended September 30, 2025 EMEA Americas eliminations Total
Cartons and closures 179 680 84 890 ( 862) 263 708
Equipment 8 918 3 073 ( 783) 11 208
Service 14 780 ( 88) ( 262) 14 430
Other 2 773 318 (2 790) 301
Total revenue 206 151 88 193 (4 696) 289 648
Quarter ended September 30, 2024 EMEA Americas Other and
eliminations
Total
Cartons and closures 184 507 69 560 ( 584) 253 484
Equipment 16 326 8 528 ( 0) 24 854
Service 14 248 - ( 355) 13 893
Other 2 622 1 233 (3 283) 572
Total revenue 217 703 79 322 (4 221) 292 804
Other and
Year to date ended September 30, 2025 EMEA Americas eliminations Total
Cartons and closures 550 538 247 487 (3 373) 794 652
Equipment 50 563 11 751 (12 622) 49 693
Service 45 573 ( 231) (1 067) 44 276
Other 9 058 1 000 (9 091) 968
Total revenue 655 732 260 008 (26 152) 889 588
Other and
Year to date ended September 30, 2024 EMEA Americas eliminations Total
Cartons and closures 568 766 209 329 (2 142) 775 953
Equipment 46 113 14 525 (8 425) 52 213
Service 44 766 - (1 102) 43 664
Other 8 094 2 340 (9 153) 1 280
Total revenue 667 739 226 194 (20 822) 873 110

Note 3 Operating segments

Information reported to the Group's chief operating decision makers, the Group Leadership Team, for the purpose of resource allocation and assessment of segment performance is focused on two key geographical regions – EMEA and Americas. Key figures representing the financial performance of these segments are presented in the following note. GLS Elopak is included in EMEA. The tables include continuing operations only.

Operating segments

(EUR 1 000)

Quarter ended September 30, 2025 EMEA Americas Other and
eliminations
Total
Revenue from contracts with customers 201 519 88 129 0 289 648
Revenue from other group segments 4 632 64 (4 697) -
Total revenue 206 151 88 193 (4 696) 289 648
Other operating income 31 - - 31
Total income 206 183 88 193 (4 696) 289 679
Operating expenses 1) (169 499) (68 354) (4 112) (241 966)
Depreciation and amortization (12 440) (3 604) (1 716) (17 759)
Impairment ( 176) - - ( 176)
Operating profit 24 068 16 235 (10 524) 29 779
EBITDA 2) 36 684 21 269 (8 809) 49 144
Adjusted EBITDA 2) 36 684 21 269 (8 809) 49 144
Purchase of non-current assets during the quarter 7 701 3 852 273 11 826

(EUR 1 000)

Quarter ended September 30, 2024 EMEA Americas Other and
eliminations
Total
Revenue from contracts with customers 214 303 78 500 0 292 804
Revenue from other group segments 3 400 821 (4 221) -
Total revenue 217 703 79 322 (4 221) 292 804
Other operating income 24 - - 24
Total income 217 727 79 322 (4 221) 292 827
Operating expenses 1) (181 776) (63 852) (3 950) (249 577)
Depreciation and amortization (13 917) (2 255) ( 395) (16 567)
Impairment ( 97) - - ( 97)
Operating profit 21 937 13 215 (8 567) 26 586
EBITDA 2) 35 948 17 600 (8 171) 45 377
Adjusted EBITDA 2) 35 948 17 600 (8 171) 45 377
Purchase of non-current assets during the quarter 11 821 13 748 3 303 28 872

1) Operating expenses include cost of materials, payroll expenses, and other operating expenses.

2) See the APM disclosure for the reconciliation of EBITDA and adjusted EBITDA.

Note 3 Operating segments

Operating segments

(EUR 1 000)

Year to date ended September 30, 2025 EMEA Americas Other and
eliminations
Total
Revenue from contracts with customers 629 541 260 047 0 889 588
Revenue from other group segments 26 192 ( 39) (26 153) -
Total revenue 655 732 260 008 (26 152) 889 588
Other operating income 34 - - 34
Total income 655 766 260 008 (26 152) 889 622
Operating expenses 1) (548 224) (207 478) ( 390) (756 092)
Depreciation and amortization (39 238) (7 941) (2 408) (49 587)
Impairment (1 246) - - (1 246)
Operating profit 67 059 44 588 (28 950) 82 698
EBITDA 2) 107 543 57 471 (26 541) 138 473
Adjusted EBITDA 2) 107 543 57 471 (26 541) 138 473
Purchase of non-current assets during the quarter 30 228 26 404 993 57 625

(EUR 1 000)

Year to date ended September 30, 2024 EMEA Americas Other and
eliminations
Total
Revenue from contracts with customers 648 425 224 400 286 873 110
Revenue from other group segments 19 314 1 794 (21 108) -
Total revenue 667 739 226 194 (20 822) 873 110
Other operating income 25 - - 25
Total income 667 764 226 194 (20 822) 873 136
Operating expenses 1) (559 005) (181 054) (4 789) (744 849)
Depreciation and amortization (40 229) (5 909) (1 230) (47 369)
Impairment ( 672) - - ( 672)
Operating profit 67 858 39 230 (26 841) 80 247
EBITDA 2) 108 758 52 121 (25 611) 135 268
Adjusted EBITDA 2) 108 758 52 121 (25 611) 135 268
Purchase of non-current assets during the quarter 29 238 37 718 1 143 68 099

1) Operating expenses include cost of materials, payroll expenses, and other operating expenses.

2) See the APM disclosure for the reconciliation of EBITDA and adjusted EBITDA.

Note 4 Taxes

The reconciliation between tax (expense) / income and accounting profit / (loss) before taxes is as follows for the

continuing operations: Quarter ended September 30 Year to date ended
(EUR 1 000) 2025 2024 2025 2024
Profit before taxes 27 185 17 196 62 090 68 537
Expected Tax (expense) income at statutory rate 1) (6 796) (4 127) (15 523) (16 449)
Tax effect of share profit/(loss) from joint ventures 358 511 1 235 1 675
Prior period adjustments 112 - (197) (1 990)
Tax effect of other permanent differences (114) 108 (142) 229
Tax effect on currency valuation 2) - 2 482 - 2 857
Withholding tax (2 559) (614) (2 608) (817)
Tax (expense) income recognised in profit or loss (9 000) (1 639) (17 234) (14 493)

1 ) The Group tax rate has been set to 25% for 2025 (24% in 2024).

Note 5 Interest-bearing loans and borrowings

Elopak has issued senior unsecured green bonds with a total amount of NOK 2.7 billion. The settlement date is May 28 of the maturity year. The bonds have been swapped to floating Euribor. Due to the cross-currency swaps not being part of net interest-bearing debt, foreign exchange fluctuations on the bonds will affect our reported leverage and appear in the income statement as FX gains or losses. The corresponding offset from the EUR/NOK cross-currency swaps will be reflected as changes in the fair value of financial instruments.

The transaction was split into three tranches:

(EUR 1 000) September 30, 2025
Currency Nominal interest rate Year of maturity Face value Carrying amount
Unsecured bond issues NOK Nibor +1.20% p.a. 2027 63 958 64 134
Unsecured bond issues NOK Nibor +1.50% p.a. 2029 123 652 123 819
Unsecured bond issues NOK 5.48% 2031 42 638 43 300

The green bonds are initially recognized at cost, being the fair value of the consideration received net of incremental cost, and subsequently measured at amortized cost using the effective interest method. The cross-currency swaps are recognized as financial income or financial expense in profit or loss, in line with the accounting policy set out in the annual IFRS financial statements for the year ended December 31, 2024.

The EUR 400 million multi currency revolving credit facility expiring in May 2025 has been repaid in full and cancelled. A new revolving credit facility has been entered into on June 12, 2024 for EUR 210 million which is available until June 2029. As of September 30, 2025 EUR 50 million is utilized.

2) The tax effect on currency valuation is only estimated in the last quarter of the year compared to 2024 where it was estimated quarterly. Elopak ASA tax filling is submitted in NOK against a functional currency in Euro.

Note 6 Equity and shareholders information

Dividend

The Board of Directors approved a dividend of EUR 0.13 per share for the financial year 2024 on May 14 2025 to be paid in two tranches. The dividend for the first installment was EUR 0.08 per share. The dividend payment was EUR 21.6 million based on 268 961 482 outstanding shares.

For the first half of 2025, the Board has declared a dividend of EUR 0.03 per share, in line with our revised dividend policy to pay semi-annual dividends. The proposed semi-annual dividend corresponds to around EUR 8.1 million, to be paid out in NOK together with the second installment of the approved dividend for the financial year 2024 of around EUR 13.5 million, in October of 2025. We remain committed to distribute annual dividends corresponding to 50-60% of the Group's normalized net profit.

Note 7 Financial risk management

September 30, 2025 September 30, 2024
(EUR 1 000) Assets Liabilities Total Assets Liabilities Total
Currency derivatives 302 5 524 (5 222) 608 10 352 (9 743)
Commodity derivatives - 245 (245) - 200 (200)
Interest derivatives 938 2 120 (1 182) 2 199 3 743 (1 544)
Total 1 239 7 889 (6 650) 2 807 14 294 (11 487)

The full fair value of a derivative is classified as "Other non-current assets" or "Other non-current liabilities" if the remaining maturity of the derivative is more than 12 months and, as "Other current assets" or "Other current liabilities", if the maturity of the derivative is less than 12 months. The fair value estimation of derivative financial instruments has been arrived at by applying a level 2 valuation methodology which uses inputs other than unadjusted quoted prices for identical assets and liabilities, with changes in fair value are therefore recognized in the income statement. No other material financial assets or liabilities are measured at fair value through profit or loss.

Where eligible, derivatives used for hedging are designated in cash flow hedge accounting relationships.

Note 8 Off-balance sheet commitments and contingencies

Commitments for the acquisition of property, plant and equipment related to the new production plant in Little Rock, Arkansas are EUR 14.2 million as of September 30, 2025 and EUR 24.7 million as of September 30, 2024.

Alternative performance measures (APMs)

The Group prepares and reports its consolidated financial statements in accordance with International Financial Reporting Standards as issued by the IASB and as endorsed by the EU (IFRS). In addition, the Group presents several Alternative Performance Measures (APMs).

In accordance with European Securities and Market Authority (ESMA) guidelines dated May 10, 2015, an APM is understood as a financial measure of historical or future financial performance, financial position, or cash flows, other than a financial measure defined or specified in the applicable financial reporting framework (IFRS). It should be noted that these measures do not have any standardized meaning prescribed by IFRS and therefore are not necessarily comparable to the calculation of similar measures used by other companies. The APMs are regularly reviewed by the Group's management. The APMs are reported in addition to but are not substitutes for the Group's consolidated financial statements, prepared in accordance with IFRS.

The APMs provide supplementary information to measure the Group's performance and to enhance comparability between financial periods. The APMs also provide measures commonly reported and widely used by investors, lender, and other stakeholders as an indicator of the Group's performance. These APMs are among other, used in planning for and forecasting future periods, including assessing our ability to incur and service debt including covenant compliance. APMs are defined consistently over time and are based on the Group's consolidated financial statements (IFRS).

Organic revenue

Organic revenue is a measure of revenue adjusted for currency effects and effects of acquisition and disposal of operations. The Group presents this APM because management considers it to provide useful supplemental information for understanding the Group's revenue development over time for comparability purposes.

Organic revenue

Quarter ended September 30, Year to date ended September 30,
(EUR 1 000) 2025 2024 Change 2025 2024 Change
Total revenue and other operating income 289 679 292 827 -1.1% 889 622 873 136 1.9%
Currency effect 6 765 9 047
Acquisition and disposal effect - -
Organic revenue 296 444 292 827 1.2% 898 669 873 136 2.9%
Quarter ended September 30, Year to date ended September 30,
(EUR 1 000) 2024 2023 Change 2024 2023 Change
Total revenue and other operating income 292 827 283 493 3.3% 873 136 844 912 3.3%
Currency effect 779 862
Acquisition and disposal effect - -
Organic revenue 293 606 283 493 3.6% 873 998 844 912 3.4%

EBITDA

EBITDA is a measure of earnings before interest, taxes, depreciation, amortization, and impairments including share of net income from joint ventures.

The Group presents this APM because management considers it to provide useful supplemental information for understanding the overall picture of profit generation in the Group's operating activities and for comparing its operating performance with that of other companies.

Adjusted EBITDA

Adjusted EBITDA is a measure of EBITDA adjusted for certain items affecting comparability (the Adjustment items). The Group presents this APM because management considers it to be an important supplemental measure for understanding the underlying profit generation in the Group's operating activities and comparing its operating performance with that of other companies.

Reconciliation of EBITDA and adjusted EBITDA

Quarter ended September 30, Year to date ended September 30,
(EUR 1 000) 2025 2024 2025 2024
Operating profit 29 779 26 586 82 698 80 247
Depreciation, amortization and impairment 17 935 16 664 50 833 48 040
Share of net income from joint ventures 1 431 2 127 4 942 6 981
EBITDA 49 144 45 377 138 473 135 268
Total adjusted items with EBITDA impact - - - -
Adjusted EBITDA 49 144 45 377 138 473 135 268

EBIT

EBIT is a measure of earnings before interests and taxes. The Group presents this APM because management considers it to provide useful supplemental information for understanding the overall picture of profit generation in the Group's operating activities and for comparing its operating performance with that of other companies.

Adjusted EBIT

Adjusted EBIT is a measure of EBIT adjusted for certain items affecting comparability (the Adjustment items). The Group presents this APM because management considers it to be an important supplemental measure for understanding the underlying profit generation in the Group's operating activities and comparing its operating performance with that of other companies.

Reconciliation of EBIT and adjusted EBIT

Quarter ended September 30, Year to date ended September 30,
(EUR 1 000) 2025 2024 2025 2024
EBITDA 49 144 45 377 138 473 135 268
Depreciation, amortization and impairment (17 935) (16 664) (50 833) (48 040)
EBIT 31 210 28 713 87 640 87 228
Total adjusted items with EBIT impact - - - -
Adjusted EBIT 31 210 28 713 87 640 87 228

Capital employed

Capital employed is defined as Shareholders' Equity, including non-controlling interest, plus net debt.

Return on capital employed (ROCE)

Return on capital employed (ROCE) is defined as adjusted EBIT for the last 4 quarters divided by the average capital employed, measured for the last 4 quarters. ROCE is an important metric for the Group to measure its capital efficiency. Since it takes into account both debt and equity, management considers this to provide a holistic view of the Group's profitability.

Return on capital employed (ROCE)

Quarter ended September 30, 2025 2025 2025 2025 2024
(EUR 1 000) Q3 Q2 Q1 Q4
Operating profit 29 779 26 738 26 181 19 209
Share of net income from joint ventures 1 431 976 2 535 2 716
EBIT 31 210 27 714 28 716 21 924
Total adjusted items with EBIT impact - - - -
Adjusted EBIT 31 210 27 714 28 716 21 924
Adjusted EBIT, last 4 quarters 109 564
Net debt 372 026 406 044 402 429 369 453
Equity 352 152 334 383 363 128 352 652
Capital employed 724 178 740 427 765 556 722 105
Capital employed, average last 4 quarters 738 066
ROCE 14.8 %

Return on capital employed (ROCE)

Quarter ended September 30, 2024 2024 2024 2024 2023
(EUR 1 000) Q3 Q2 Q1 Q4
Operating profit 26 586 25 816 27 846 22 252
Share of net income from joint ventures 2 127 2 605 2 248 2 753
EBIT 28 713 28 421 30 094 25 005
Total adjusted items with EBIT impact - - - ( 100)
Adjusted EBIT 28 713 28 421 30 094 24 905
Adjusted EBIT, last 4 quarters 112 133
Net debt 371 250 338 510 313 231 332 545
Equity 329 657 325 284 341 603 315 296
Capital employed 700 907 663 794 654 834 647 841
Capital employed, average last 4 quarters 666 844
ROCE 16.8 %

Adjusted profit attributable to Elopak shareholders

Adjusted profit attributable to Elopak shareholders represents the Group's profit attributable to Elopak shareholders adjusted for certain items affecting comparability, taking into account the Adjustment items, related estimated calculatory tax effects based on a 25% statutory tax rate and excluding historical share of net income from joint ventures that have been discontinued. The Group presents this APM because management considers it to provide useful supplemental information for understanding the Group's profit attributable to Elopak shareholders and for comparability purposes with other companies.

Adjusted profit attributable to Elopak shareholders

Quarter ended September 30, Year to date ended September 30,
(EUR 1 000) 2025 2024 2025 2024
Profit attributable to Elopak shareholders 18 138 15 169 44 336 52 540
Discontinued operations - - - 131
Items excluded from adjusted EBITDA net of tax - - - -
Adjusted profit attributable to Elopak shareholders 18 138 15 169 44 336 52 672

Net debt

Net debt is a measure of borrowings (including liabilities to financial institutions before amortization costs and including lease liabilities) less cash and cash equivalents for the period. The Group presents this APM because management considers it as a useful indicator of the Group's indebtedness, financial flexibility and capital structure because it indicates the level of borrowings after taking into account cash and cash equivalents within the Group's business that could be utilized to pay down outstanding borrowings. Net debt is also used for monitoring the Group's financial covenants compliance by management.

Net debt/adjusted EBITDA (Leverage ratio)

Leverage ratio is a measure of net debt divided by adjusted EBITDA. The Group presents this APM because management considers it as a useful indicator of the Group's ability to meet its financial obligations. Net debt/adjusted EBITDA is also used for monitoring the Group's financial covenants compliance by management.

Net debt and leverage ratio

Quarter ended September 30,

(EUR 1 000) 2025 2024
Bank debt 1) 281 253 233 606
Overdraft facilities 29 927 52 908
Cash and equivalents (39 077) (21 325)
Net bank debt 272 103 265 189
Lease liabilities 99 923 106 061
Net debt 372 026 371 250

1) Bank debt is excluding amortized borrowing costs of EUR 0.7 million as of September 30, 2025 and EUR 0.9 million as of September 30, 2024.

Leverage ratio 2) 2.1 2.1
------------------- ----- -----

2) Leverage ratio is calculated based on last twelve months adjusted EBITDA of EUR 179.3 million as of September 30, 2025 and EUR 175.3 million as of September 30, 2024.

Adjusted basic and diluted earnings per share (Adjusted EPS)

Adjusted EPS represents adjusted profit attributable to Elopak shareholders divided by weighted average number of ordinary shares – basic and diluted. Elopak presents adjusted basic and diluted earnings per share because management considers it to be an important supplemental measure for understanding the Group's underlying profit for the year (period) on a per share basis and comparing its profit for the year (period) on a per share basis with that of other companies in the industry.

Adjusted Earnings per share

Quarter ended September 30, Year to date ended September 30,
(EUR 1 000 except number of shares) 2025 2024 2025 2024
Weighted-average number of ordinary shares 268 939 116 269 102 166 268 944 615 269 048 522
Profit attributable to Elopak shareholders 18 138 15 169 44 336 52 540
Adjusted profit attributable to Elopak shareholders 18 138 15 169 44 336 52 672
Basic and diluted earnings per share attributable to Elopak
shareholders (in EUR)
0.07 0.06 0.16 0.20
Adjusted basic and diluted earnings per share (in EUR) 0.07 0.06 0.16 0.20

Reconciliation of net income from joint ventures

Quarter ended September 30, Year to date ended September 30,
(EUR 1 000) 2025 2024 2025 2024
Lala Elopak S.A. de C.V. 862 1 652 2 721 5 354
Impresora Del Yaque 569 478 2 220 1 628
Elopak Nampak Africa Ltd 0 ( 3) 0 ( 1)
Total share of profit joint ventures 1 431 2 127 4 942 6 981

Additional information

Contact information

Christian Gjerde

Treasury and Investor Relations +47 980 60 909

Bent Axelsen

Chief Financial Officer +47 977 56 578

Financial calendar

February 10, 2026 Quarterly Report – Q4 May 5, 2026 Quarterly Report – Q1 August 18, 2026 Half-yearly Report October 27, 2026 Quarterly Report – Q3

Elopak reserves the right to revise the dates

Cautionary note

The interim report contains certain forward-looking statements. Forward-looking statements are statements that are not historical facts and may be identified by words such as "plans", "targets", "aims", "believes", "expects", "anticipates", "intends", "estimates", "will", "may", "continues", "should" and similar expressions. Any statement, estimate or projections included in the Information (or upon which any of the conclusions contained herein are based) with respect to anticipated future performance (including, without limitation, any statement, estimate or projection with respect to the condition (financial or otherwise), prospects, business strategy, plans or objectives of the Group and/or any of its affiliates) reflect, at the time made, the Company's beliefs, intentions and current targets/ aims and may prove not to be correct. Although the Company believes that these assumptions were reasonable when made, these assumptions are inherently subject to significant known and unknown risks, uncertainties, contingencies and other important factors which are difficult or impossible to predict and are beyond its control. No representation or warranty is given as to the completeness or accuracy of any forward-looking statement contained in the Information or the accuracy of any of the underlying assumptions.

This is Elopak

As worldwide makers of carton based packaging, we are committed to remaining our customers' partner and the consumers' favorite, through relentlessly developing new solutions for an expanding range of content.

Applying market-leading technology, skills and natural material sourcing, we always aim to provide the highest quality products that leave the world unharmed.

For more information please visit www.elopak.com

Talk to a Data Expert

Have a question? We'll get back to you promptly.